Christopher Lull

Christopher Lull has a diverse work experience in the field of business development and scientific research. Christopher is currently employed at ATEM Structural Discovery as a Business Development Manager/Growth Manager, a role they started in October 2022. Prior to this, Christopher worked at ProtaGene from January 2022 to October 2022 as a Business Development Manager for CGTx translational and analytical services. Christopher also has experience at Protagen Protein Services GmbH, where they held two roles simultaneously from May 2020 to October 2022: Business Development Manager for Cell & Gene Therapy and Business Development Manager for Developability Study. Christopher's earlier experience includes working as a Scientist for drafting solutions in Infectiology at University Hospital Essen from October 2018 to April 2020.

Christopher Lull obtained a Bachelor of Science degree in Biochemistry and Molecular Biology from Ruhr University Bochum, which they completed between 2011 and 2014. Following their bachelor's degree, Christopher pursued further education at Ruhr University Bochum and successfully completed a Master of Science degree in Biochemistry and Molecular Biology from 2014 to 2017.